Trial Information

Summary: Pediatric Asthma Study CMFF258C2204

Novartis Pharmaceuticals is being conducting this clinical trial study to find out if combining the investigational drugs formoterol and mometasone while using an inhaler device called a pressurized metered dose inhaler (pMDI), is effective and safe for children between 5 and 11 years old with persistent asthma when compared to placebo (non active medicine). This clinical research study also aims to find out if formoterol given on its own using the pMDI has the same beneficial effects as formoterol given on its own using another inhaler device called the Aerolizer®. An ?investigational drug? is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).?
Participants will be required to make at least 5 visits (and a possible 6th optional screening visit) to the study center, with at least 6 to 7 days between each visit.

www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 21, 2008 at 2:56:45 PM